Global Angiotensin Converting Enzyme Assay Kit Market Growth 2025-2031
Description
The global Angiotensin Converting Enzyme Assay Kit market size is predicted to grow from US$ 422 million in 2025 to US$ 657 million in 2031; it is expected to grow at a CAGR of 7.7% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The angiotensin converting enzyme (ACE) assay kit is an in vitro diagnostic tool based on the FAPGG substrate method. It quantitatively determines the ACE activity in human serum or plasma by detecting the hydrolysis reaction rate of ACE to the FAPGG substrate. The principle is that ACE catalyzes FAPGG to generate a colorable product (such as p-nitroaniline), and the absorbance/fluorescence intensity is measured by spectrophotometry or fluorescence to calculate the ACE concentration (the detection range is usually 6.25-200 U/μL, the sensitivity is 1.0 U/μL), widely used in auxiliary diagnosis of hypertension, heart failure and cardiovascular diseases; there is no direct statistical data on the global ACE assay kit market size in 2024, but combined with the size of China's ACEI drug market (about RMB 4.77 billion in 2024, with a compound annual growth rate of 3.1%) and the penetration rate of diagnostic reagents in the cardiovascular field (assuming it accounts for 5%-8% of the cardiovascular diagnostic reagent market), and referring to the annual size of the global cardiovascular diagnostic market of about US$15 billion, it is estimated that the global market size of ACE assay kits is about US$300-500 million, mainly driven by the Chinese market (about US$200-300 million) and mature markets such as Europe, the United States and Japan. Future growth will benefit from the increase in demand for early screening of chronic diseases, the development of companion diagnostic drugs (such as monitoring the efficacy of new ACE inhibitors) and the popularization of POCT equipment.
United States market for Angiotensin Converting Enzyme Assay Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Angiotensin Converting Enzyme Assay Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Angiotensin Converting Enzyme Assay Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Angiotensin Converting Enzyme Assay Kit players cover Sigma Aldrich, Thermo Fisher, Nagase, Abcam, Abbexa, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Angiotensin Converting Enzyme Assay Kit Industry Forecast” looks at past sales and reviews total world Angiotensin Converting Enzyme Assay Kit sales in 2024, providing a comprehensive analysis by region and market sector of projected Angiotensin Converting Enzyme Assay Kit sales for 2025 through 2031. With Angiotensin Converting Enzyme Assay Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Angiotensin Converting Enzyme Assay Kit industry.
This Insight Report provides a comprehensive analysis of the global Angiotensin Converting Enzyme Assay Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Angiotensin Converting Enzyme Assay Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Angiotensin Converting Enzyme Assay Kit market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Angiotensin Converting Enzyme Assay Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Angiotensin Converting Enzyme Assay Kit.
This report presents a comprehensive overview, market shares, and growth opportunities of Angiotensin Converting Enzyme Assay Kit market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Continuous Monitoring Method
FAPGG Substrate Method
Others
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sigma Aldrich
Thermo Fisher
Nagase
Abcam
Abbexa
STEMCELL Technologies
Sangon Biotech
Life Origin Biotech
BIOSINO
CELL RESEARCH
Beijing Shijiwode
Epizyme
Biosharp
Dalian Meilunhelper
Key Questions Addressed in this Report
What is the 10-year outlook for the global Angiotensin Converting Enzyme Assay Kit market?
What factors are driving Angiotensin Converting Enzyme Assay Kit market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Angiotensin Converting Enzyme Assay Kit market opportunities vary by end market size?
How does Angiotensin Converting Enzyme Assay Kit break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The angiotensin converting enzyme (ACE) assay kit is an in vitro diagnostic tool based on the FAPGG substrate method. It quantitatively determines the ACE activity in human serum or plasma by detecting the hydrolysis reaction rate of ACE to the FAPGG substrate. The principle is that ACE catalyzes FAPGG to generate a colorable product (such as p-nitroaniline), and the absorbance/fluorescence intensity is measured by spectrophotometry or fluorescence to calculate the ACE concentration (the detection range is usually 6.25-200 U/μL, the sensitivity is 1.0 U/μL), widely used in auxiliary diagnosis of hypertension, heart failure and cardiovascular diseases; there is no direct statistical data on the global ACE assay kit market size in 2024, but combined with the size of China's ACEI drug market (about RMB 4.77 billion in 2024, with a compound annual growth rate of 3.1%) and the penetration rate of diagnostic reagents in the cardiovascular field (assuming it accounts for 5%-8% of the cardiovascular diagnostic reagent market), and referring to the annual size of the global cardiovascular diagnostic market of about US$15 billion, it is estimated that the global market size of ACE assay kits is about US$300-500 million, mainly driven by the Chinese market (about US$200-300 million) and mature markets such as Europe, the United States and Japan. Future growth will benefit from the increase in demand for early screening of chronic diseases, the development of companion diagnostic drugs (such as monitoring the efficacy of new ACE inhibitors) and the popularization of POCT equipment.
United States market for Angiotensin Converting Enzyme Assay Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Angiotensin Converting Enzyme Assay Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Angiotensin Converting Enzyme Assay Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Angiotensin Converting Enzyme Assay Kit players cover Sigma Aldrich, Thermo Fisher, Nagase, Abcam, Abbexa, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Angiotensin Converting Enzyme Assay Kit Industry Forecast” looks at past sales and reviews total world Angiotensin Converting Enzyme Assay Kit sales in 2024, providing a comprehensive analysis by region and market sector of projected Angiotensin Converting Enzyme Assay Kit sales for 2025 through 2031. With Angiotensin Converting Enzyme Assay Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Angiotensin Converting Enzyme Assay Kit industry.
This Insight Report provides a comprehensive analysis of the global Angiotensin Converting Enzyme Assay Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Angiotensin Converting Enzyme Assay Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Angiotensin Converting Enzyme Assay Kit market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Angiotensin Converting Enzyme Assay Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Angiotensin Converting Enzyme Assay Kit.
This report presents a comprehensive overview, market shares, and growth opportunities of Angiotensin Converting Enzyme Assay Kit market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Continuous Monitoring Method
FAPGG Substrate Method
Others
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sigma Aldrich
Thermo Fisher
Nagase
Abcam
Abbexa
STEMCELL Technologies
Sangon Biotech
Life Origin Biotech
BIOSINO
CELL RESEARCH
Beijing Shijiwode
Epizyme
Biosharp
Dalian Meilunhelper
Key Questions Addressed in this Report
What is the 10-year outlook for the global Angiotensin Converting Enzyme Assay Kit market?
What factors are driving Angiotensin Converting Enzyme Assay Kit market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Angiotensin Converting Enzyme Assay Kit market opportunities vary by end market size?
How does Angiotensin Converting Enzyme Assay Kit break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
115 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Angiotensin Converting Enzyme Assay Kit by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Angiotensin Converting Enzyme Assay Kit by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
